Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Slebos

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|May 1, 1992
Clinical significance of ras oncogene activation in human lung cancerS Rodenhuis, R J Slebos
The American Review of Respiratory Disease|December 1, 1990
The ras oncogenes in human lung cancerS Rodenhuis, R J Slebos
Journal of the National Cancer Institute. Monographs|January 1, 1992
The ras gene family in human non-small-cell lung cancerR J Slebos, S Rodenhuis
The European Respiratory Journal|May 1, 1989
The molecular genetics of human lung cancerR J Slebos, S Rodenhuis
Biochemical and Biophysical Research Communications|February 17, 2001
A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell linesR J Slebos, J A Taylor
Nederlands Tijdschrift Voor Geneeskunde|December 30, 1995
[Molecular-genetic detection of colorectal carcinoma in the feces]G J Offerhaus, R J Slebos
International Journal of Cancer|September 9, 1991
Radiosensitivity of small-cell lung cancer xenografts compared with activity of c-myc, N-myc, L-myc, c-raf-1 and K-ras proto-oncogenesK Rygaard, R J Slebos, M Spang-Thomsen
Cancer Chemotherapy and Pharmacology|January 1, 1988
Resistance to cisplatin and analogues: mechanisms and potential clinical implicationsA de Graeff, R J Slebos, S Rodenhuis
Cancer Research|December 16, 1998
Inactivation of the p53 tumor suppressor gene via a novel Alu rearrangementR J Slebos, M A Resnick, J A Taylor
Biochemical and Biophysical Research Communications|August 26, 1998
Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor proteinH M Ceha, I Nasser, R H Medema, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|May 1, 1992
Clinical significance of ras oncogene activation in human lung cancerS Rodenhuis, R J Slebos
The American Review of Respiratory Disease|December 1, 1990
The ras oncogenes in human lung cancerS Rodenhuis, R J Slebos
Journal of the National Cancer Institute. Monographs|January 1, 1992
The ras gene family in human non-small-cell lung cancerR J Slebos, S Rodenhuis
The European Respiratory Journal|May 1, 1989
The molecular genetics of human lung cancerR J Slebos, S Rodenhuis
Biochemical and Biophysical Research Communications|February 17, 2001
A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell linesR J Slebos, J A Taylor
Nederlands Tijdschrift Voor Geneeskunde|December 30, 1995
[Molecular-genetic detection of colorectal carcinoma in the feces]G J Offerhaus, R J Slebos
International Journal of Cancer|September 9, 1991
Radiosensitivity of small-cell lung cancer xenografts compared with activity of c-myc, N-myc, L-myc, c-raf-1 and K-ras proto-oncogenesK Rygaard, R J Slebos, M Spang-Thomsen
Cancer Chemotherapy and Pharmacology|January 1, 1988
Resistance to cisplatin and analogues: mechanisms and potential clinical implicationsA de Graeff, R J Slebos, S Rodenhuis
Cancer Research|December 16, 1998
Inactivation of the p53 tumor suppressor gene via a novel Alu rearrangementR J Slebos, M A Resnick, J A Taylor
Biochemical and Biophysical Research Communications|August 26, 1998
Several noncontiguous domains of CDK4 are involved in binding to the P16 tumor suppressor proteinH M Ceha, I Nasser, R H Medema, et al.
Pageof 5